Origin GTM brain

Origin produces and licenses patient-derived multimodal cancer datasets to pharmaceutical and AI research teams.

category

Oncology spatial data licensing

market profile

  • text: Oncology researchers need patient-level data that captures tumor heterogeneity to improve biomarker discovery and trial design.
  • text: Multimodal oncology datasets are available from established biopharma data and spatial omics providers.

personas

  • title: Head of translational oncology
    pains:
    • Trial response varies across biologically heterogeneous tumors
    • Teams need matched molecular, image and clinical information to identify useful patient subgroups
  • title: Computational biology or oncology AI lead
    pains:
    • Training data is fragmented across modalities and cohorts
    • Bespoke datasets can require substantial tissue processing and quality control
  • title: Biopharma external innovation or data partnerships lead
    pains:
    • Licensing agreements and data evaluation require alignment with scientific users
    • Sourcing appropriately annotated patient cohorts takes time

icp

  • text: Pharmaceutical and biotechnology companies running oncology biomarker or patient stratification programs.
  • text: AI labs building oncology models that need licensed spatial transcriptomics, pathology images and clinical labels.

message pillars

  • text: Start with real patient tissue to map disease.
  • text: Pair complementary tumor data modalities.
  • text: Support both existing and custom cohort needs.

objections

  • objection: Does the dataset fit our indication and endpoints?
    response: Request a cohort inventory and evaluate sample annotations and data quality against the intended study.
  • objection: Are the samples and clinical data appropriate for research use?
    response: Review provenance, anonymization, consent and licensing terms with the data provider and legal team.

competitors

  • name: Owkin
    website: https://www.owkin.com/data/mosaic
    why: MOSAIC combines spatial omics and clinical data for oncology research.
  • name: Caris Life Sciences
    website: https://www.carislifesciences.com/biopharma/multimodal-data/
    why: Provides multimodal oncology data and biopharma research partnerships.
  • name: Tempus
    why: Licenses multimodal oncology research data to life sciences teams.

influencers

  • name: Yash Rathod
    why: Origin co-founder and CEO identified in company coverage.
  • name: Malhar Bhide
    why: Origin co-founder and CTO identified in company coverage.

keywords

  • spatial transcriptomics oncology dataset
  • matched pathology and transcriptomics data
  • cancer clinical data licensing
  • tumor microenvironment dataset
  • oncology AI training data
  • patient stratification biomarkers

voice

  • research-driven
  • ambitious
  • evidence-led

signals

  • text: A pharma team is designing oncology biomarker studies or responder-enriched trials.
  • text: An AI lab is seeking multimodal patient tumor data for model training.

stack

  • spatial transcriptomics
  • H&E imaging

hiring

  • Head of Data Partnerships

pricing

model: unknown

motion

sales_led

channels

  • YC directory
  • research
  • direct partnerships

confidence

medium

Founders

  • name: Yash Rathod
    title: Founder/CEO
    role: CEO
    bio: CEO @ Origin | Computer Science @ UIUC, Computer Vision and Reinforcement Learning Research, First Prize 2022 OpenCV AI Research Competition.
  • name: Malhar Bhide
    title: Founder/CTO
    role: CTO
    bio: CTO @ Origin | Prev: Computer Science @ UIUC, ML Research @ Wadhwani AI, Automorphic (YC S23). Published disease modeling research done in high school in Nature Scientific Reports.

Back to YC companies